Brawn Biotech Ltd

AI
Brawn Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Brawn Biotech Ltd

₹ 23.1 -0.47%
25 Aug 4:01 p.m.
brawnbiotech.com BSE: 530207
About

Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products[1]

Key Points

Business Overview:[1]
BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments:
a) Antibacterial
b) Cardiovascular
c) Antidiabetics
d) Analgesics
e) Gastrointestinal
f) Antifungals
g) Skin Care
h) Antipsychotics,
i) Anti-asthmatics
j) Antacids
k) Antimalarial
l) Nutritional

Website BSE
  • Market Cap ₹ 6.92 Cr.
  • Current Price ₹ 23.1
  • High / Low ₹ 24.4 / 17.7
  • Stock P/E 53.2
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Mar 2023 Jun 2023
0.12 0.12 0.12
0.09 0.08 0.16
Operating Profit 0.03 0.04 -0.04
OPM % 25.00% 33.33% -33.33%
0.00 0.23 0.00
Interest 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00
Profit before tax 0.03 0.27 -0.04
Tax % 0.00% 14.81% 0.00%
0.02 0.23 -0.04
EPS in Rs 0.07 0.77 -0.13
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
0.48
0.49
Operating Profit -0.01
OPM % -2.08%
0.24
Interest 0.00
Depreciation 0.01
Profit before tax 0.22
Tax % 18.18%
0.19
EPS in Rs 0.63
Dividend Payout % 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: -5%
5 Years: 2%
3 Years: 2%
1 Year: 11%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Domestic revenue share
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Export revenue share
% ・Standalone data
Inventory of traded goods
Thousand Rs. ・Standalone data
Number of permanent employees
employees ・Standalone data
Number of therapeutic segments covered
segments ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
53.72% 53.72% 53.64% 53.64% 53.64% 53.64% 53.66% 53.66% 53.66% 53.39% 52.94% 52.94%
0.59% 0.59% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35%
45.69% 45.69% 46.02% 46.02% 46.02% 46.02% 46.01% 46.00% 45.99% 46.27% 46.72% 46.72%
No. of Shareholders 6,1946,1394,1604,0904,1574,0604,0243,9753,9583,4443,3033,284

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports